Thyrocare Technologies CEO, MD, chairman, board of directors and AGM
NSE: THYROCAREBSE: 539871Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹472.10.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,372 Cr673rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 41.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 7 May 2026
- 12.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 31.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 37.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 7 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,67,87146.1% delivered
Thyrocare Technologies board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing director and CEORahul Guha
- Company Secretary and Compliance OfficerMr. Brijesh Kumar
9 directors5 independent1 executive3 non-executive
- Rahul Guha · Chairperson and managing director and CEOExecutive · joined May 2022 · 1 listed board · 4 committee seats
- Nishant A ShahIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- Anandh SundarIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 1 as chair
- Prapti Ishwar GiladaIndependent · joined Jul 2023 · reappointed Jul 2023 · 38 months as independent · 1 listed board · 1 as independent · 3 committee seats, 1 as chair
- Harshil Jiten VoraIndependent · joined Jul 2023 · reappointed Jul 2023 · 38 months as independent · 1 listed board · 1 as independent
- Indumati GopinathanIndependent · joined Aug 2017 · reappointed Mar 2024 · 90 months as independent · 2 listed boards · 2 as independent
- Gaurav VermaNon-executive · joined May 2026 · 1 listed board
- Uday Patel KadamNon-executive · joined May 2026 · 1 listed board · 2 committee seats
- Alok Kumar JagnaniNon-executive · joined Jul 2025 · 1 listed board · 2 committee seats
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
3 directors who left
- Dharmil Nirupam Sheth, left 8 May 2026: Others
- Dhaval Rajesh Shah, left 8 May 2026: Others
- Hardik Kishor Dedhia, left 23 Jul 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 21 Sep 20269 of 9 present5 independent · 59 days in between
- 23 Jul 20269 of 9 present5 independent · 76 days in between
- 7 May 20269 of 9 present5 independent
Audit Committee
Chair Nishant A Shah
Anandh Sundar, Prapti Ishwar Gilada, Rahul Guha
- 21 Sep 20264 of 4 present3 independent · 59 days in between
- 23 Jul 20264 of 4 present3 independent · no day in between
- 22 Jul 20264 of 4 present3 independent · 75 days in between
- 7 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Prapti Ishwar Gilada
Indumati Gopinathan, Alok Kumar Jagnani
- 7 May 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair Prapti Ishwar Gilada
Alok Kumar Jagnani, Rahul Guha
- 23 Jul 20263 of 3 present1 independent · 76 days in between
Risk Management Committee
Chair Prapti Ishwar Gilada
Rahul Guha, Alok Kumar Jagnani
- 7 May 20264 of 4 present1 independent
Corporate Social Responsibility Committee
Chair Indumati Gopinathan
Rahul Guha, Alok Kumar Jagnani
- 7 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- MSKA & ASSOCIATES LLP (Formerly Known as MSKA & Associates)Peer-review certificate valid to Jul 2027
1 earlier auditor
- MSKA & AssocaitesNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Thyrocare Technologies AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Thyrocare Technologies dividend history
Annual general meeting, 30 Jun 2026
74,788 shareholders on the register on 23 Jun 2026; present: 1 promoter and 65 others; votes counted by Bhavesh Chheda / M/s. Bhavesh Chheda & Associates, Practising Company Secretaries.The company's voting result (opens in a new tab)
To receive, consider and adopt: a) the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the Board’s Report and the Auditors’ Report thereon; and b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2026, together with the Auditors’ Report thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.19%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
To declare a final dividend of Rs. 7.00/- per equity share and to confirm the payment of interim dividend of Rs. 7.00/- per equity share (pre-bonus issue) [equivalent to Rs. 2.33 per equity share post bonus adjustment] on equity share having face value of Rs. 10/- each for the financial year ended March 31, 2026MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.63%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
- To re-appoint Mr. Alok Kumar Jagnani (DIN: 00644360), who retires by rotation and being eligible, offers himself for re-appointmentOrdinary99.54% for0.46% against
Against: promoters 0.00% · institutions 1.62% · other public 1.52%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
To appoint M/s. Price Waterhouse Chartered Accountants LLP (ICAI Firm Registration No. 012754N/N500016), Chartered Accountants, as Statutory Auditors of the Company for a first term of five consecutive years and to fix their remunerationMoreLess
Special100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.50%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
- Ratification of the remuneration of M/s. Jitender Navneet & Co., Cost Accountants, the Cost Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.44%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
- Approval for entering into Material Related Party Transactions with Docon Technologies Private Limited.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.28%
Turnout: all 23.93% · promoters 0.00% · institutions 90.77% · other public 0.18%
- Approval for the appointment of Mr. Gaurav Verma (DIN: 11692586) as Director (Non-Executive and Non-Independent) of the Company with effect from May 08, 2026Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.08% · other public 1.51%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
- Approval for the appointment of Mr. Uday Patel Kadam (DIN: 09277168) as Director (Non- Executive and Non-Independent) of the Company with effect from May 08, 2026Ordinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.08% · other public 1.50%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
Approval for the re-appointment of Mr. Rahul Franklin Guha (DIN: 09588432) as Chairman, Managing Director (MD) and Chief Executive Officer (CEO) of the Company with effect from May 04, 2027 and approve the remuneration payable to him.MoreLess
Ordinary97.38% for2.62% againstAgainst: promoters 0.00% · institutions 9.30% · other public 2.16%
Turnout: all 84.78% · promoters 100.00% · institutions 90.50% · other public 0.18%
- Approval for the amendment in the Memorandum of Association (MOA) of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.42%
Turnout: all 84.85% · promoters 100.00% · institutions 90.77% · other public 0.18%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 16 Nov 2025, 3 resolutions
55,647 shareholders on the register on 14 Oct 2025; votes counted by Vaibhav Dandawate / Makarand M. Joshi & Co.The company's voting result (opens in a new tab)
- Increase in the Authorised Share Capital and consequent alteration to the Capital Clause of the Memorandum of Association of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.29%
Turnout: all 85.69% · promoters 100.00% · institutions 80.82% · other public 0.10%
- Alteration of the Articles of AssociationSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 5.26%
Turnout: all 85.69% · promoters 100.00% · institutions 80.82% · other public 0.10%
- Issuance of Bonus SharesOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.74%
Turnout: all 85.69% · promoters 100.00% · institutions 80.82% · other public 0.10%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 26 Sep 2025, 1 resolution
54,112 shareholders on the register on 22 Aug 2025; votes counted by Devesh Kumar Vasisht / DPV & Associates LLP.The company's voting result (opens in a new tab)
- Appointment of Mr. Alok Kumar Jagnani (DIN: 00644360) as a Director (Non- Executive & Non- Independent) of the Company.Ordinary99.92% for0.08% against
Against: promoters 0.00% · institutions 0.44% · other public 0.43%
Turnout: all 86.30% · promoters 100.00% · institutions 81.12% · other public 1.56%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 31 Jul 2025, 6 resolutions
54,588 shareholders on the register on 25 Jul 2025; present: 1 promoter and 64 others; votes counted by Mehul Pitroda / M S Pitroda.The company's voting result (opens in a new tab)
To receive, consider and adopt: (a) the Audited Standalone Financial Statements of the Company for the Financial Year ended on March 31, 2025; together with the Board’s Report and the Auditors’ Report thereon; and (b) the Audited Consolidated Financial Statements of the Company for the Financial Year ended on March 31, 2025, together with the Auditors’ Report thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 86.10% · promoters 100.00% · institutions 82.45% · other public 2.52%
- To declare a Final Dividend of ₹ 21 per equity share of the face value of ₹ 10 each for the Financial Year ended on March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 86.10% · promoters 100.00% · institutions 82.45% · other public 2.52%
- To re-appoint Dr. Dhaval Shah (DIN: 07485688), who retires by rotation, and being eligible, offers himself for re-appointmentOrdinary99.93% for0.07% against
Against: promoters 0.00% · institutions 0.42% · other public 0.06%
Turnout: all 86.10% · promoters 100.00% · institutions 82.45% · other public 2.52%
- Ratification of Remuneration to the Cost Auditors for the financial year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 86.10% · promoters 100.00% · institutions 82.45% · other public 2.51%
- Approval for entering into material related party transactions with Docon Technologies Private LimitedOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 14.93% · promoters 0.00% · institutions 82.45% · other public 1.45%
- Appointment of Secretarial Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 86.10% · promoters 100.00% · institutions 82.45% · other public 2.52%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 9 Jan 2025, 1 resolution
57,670 shareholders on the register on 6 Dec 2024; votes counted by Vishal Thawani / Vishal Thawani & Associates.The company's voting result (opens in a new tab)
- Extension of the Thyrocare Employees Stock Option Scheme to eligible employee(s) of the Holding and/or Subsidiary Companies of the Company.Special87.40% for12.60% against
Against: promoters 0.00% · institutions 75.68% · other public 0.23%
Turnout: all 85.87% · promoters 100.00% · institutions 82.27% · other public 4.16%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 23 Aug 2024, 8 resolutions
Present: 1 promoter and 38 others.The company's voting result (opens in a new tab)
1 - (a)tTo adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2024, together with the Board’s Report and the Auditors’ Report thereon; andnn(b)t To adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2024, together with the Auditors’ Report thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.17%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To declare dividend of Rs.18/- per equity share of face value of Rs.10/- each for the financial year 2023-24.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.13%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To appoint a director in the place of Mr. Hardik Dedhia (DIN: 06660799), who retires by rotation, and being eligible, offers himself re-appointment.Ordinary99.95% for0.05% against
Against: promoters 0.00% · institutions 0.31% · other public 0.25%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To approve appointment of Mr. Nishant Amilal Shah (DIN: 09025935) as an Independent Director.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.29%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To approve appointment of Mr. Anandh Sundar (DIN: 10409065) as an Independent Director.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.29%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To ratify / approve the remuneration fixed for the cost auditor for the financial year 2024-25.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.73%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
- To approve entering into material related party transactions with Docon Technologies Private Limited.OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.45%
Turnout: all 14.45% · promoters 0.00% · institutions 85.05% · other public 0.63%
- To authorise the Board to make investments, give loans, guarantees and security in excess of limits specified under Section 186 of the Companies Act, 2013.Special83.73% for16.27% against
Against: promoters 0.00% · institutions 97.00% · other public 1.16%
Turnout: all 85.66% · promoters 100.00% · institutions 85.05% · other public 1.51%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 10 Aug 2023, 11 resolutions
Present: 1 promoter and 36 others.The company's voting result (opens in a new tab)
To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2023, together with the Board’s Report and the Auditors’ Report thereon; and the audited consolidated financial statements of the Company for the financial year ended March 31, 2023, together with the Auditors’ Report thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.39%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
- To confirm the payment of Interim Dividend of Rs.18/- per equity share already paid for the Financial Year 2022-23 and treat it as the Final Dividend for the financial year 2022-23Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.09%
Turnout: all 85.06% · promoters 100.00% · institutions 80.55% · other public 0.99%
- To appoint a Director in the place of Mr. Dharmil Sheth (DIN: 06999772), who retires by rotation, and being eligible, offers himself for re-appointmentOrdinary99.98% for0.02% against
Against: promoters 0.00% · institutions 0.10% · other public 0.77%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
- Appointment of Mr. Rahul Guha (DIN: 09588432), Managing Director and Chief Executive Officer as Chairman of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.01% · other public 2.85%
Turnout: all 85.37% · promoters 100.00% · institutions 82.83% · other public 0.27%
- Reappointment of Dr. Indumati Gopinathan (DIN: 06779331) as a Non-Executive Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.03%
Turnout: all 85.17% · promoters 100.00% · institutions 81.15% · other public 0.99%
- Appointment of Dr. Prapti Ishwar Gilada (DIN: 07125024) as a Non-Executive Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.79%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
- Appointment of Dr. Harshil Jiten Vora (DIN:10232581) as a Non-Executive Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.78%
Turnout: all 85.35% · promoters 100.00% · institutions 82.23% · other public 0.99%
- Ratification of remuneration to the cost auditor for the financial year 2023-24Ordinary99.83% for0.17% against
Against: promoters 0.00% · institutions 0.98% · other public 2.45%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
- Approval for entering into material related party transactions with Docon Technologies Private LimitedOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 3.06%
Turnout: all 14.22% · promoters 0.00% · institutions 82.83% · other public 0.23%
- Amendment in the Employee Stock Option SchemeSpecial99.82% for0.18% against
Against: promoters 0.00% · institutions 1.10% · other public 1.14%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
Granting of Employees Stock Option for financial year 2023-24 and subsequent years in accordance with the revised scheme until the remaining 218,662 stock options are fully utilised and equivalent no. of shares and issued and allottedMoreLess
Special99.82% for0.18% againstAgainst: promoters 0.00% · institutions 1.10% · other public 1.22%
Turnout: all 85.46% · promoters 100.00% · institutions 82.83% · other public 0.99%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 3 Aug 2022, 11 resolutions
Present: 1 promoter and 41 others.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Stand-alone Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Board’s Report and Auditors’ Report thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 88.87% · promoters 100.00% · institutions 88.47% · other public 0.41%
- To receive, consider and adopt the Consolidated Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Auditors’ Report thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 88.87% · promoters 100.00% · institutions 88.47% · other public 0.41%
- To confirm the payment of Interim Dividend of Rs.15/- per equity share already paid, and approve it as the Final Dividend for the Financial Year 2021-22Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.01%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
- TO APPROVE THE APPOINTMENT OF MR. DHARMIL SHETH (DIN: 06999772) AS A DIRECTOR LIABLE TO RETIRE BY ROTATIONOrdinary99.95% for0.05% against
Against: promoters 0.00% · institutions 0.26% · other public 2.03%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
- TO APPROVE THE APPOINTMENT OF MR. HARDIK DEDHIA (DIN: 06660799) AS A DIRECTOR LIABLE TO RETIRE BY ROTATIONOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.02%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
- TO APPROVE THE APPOINTMENT OF DR. DHAVAL SHAH (DIN: 07485688) AS DIRECTOR LIABLE TO RETIRE BY ROTATIONOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.99%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
TO APPROVE THE APPOINTMENT OF MR_RAHUL GUHA (DIN: 09588432) AS, MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER OF THE COMPANY, NOT LIABLE TO RETIRE BY ROTATION AND APPROVE THE REMUNERATION PAYABLE TO HIMMoreLess
Special96.08% for3.92% againstAgainst: promoters 0.00% · institutions 30.09% · other public 1.80%
Turnout: all 81.89% · promoters 100.00% · institutions 53.50% · other public 0.41%
- RATIFICATION OF REMUNERATION TO THE COST AUDITOR FOR THE FINANCIAL YEAR 2021-22nOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.57%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
- RATIFICATION OF REMUNERATION TO THE COSTn AUDITOR FOR THE FINANCIAL YEAR 2022-23nOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.57%
Turnout: all 88.92% · promoters 100.00% · institutions 88.69% · other public 0.41%
- APPROVAL FOR ENTERING INTO MATERIALn RELATED PARTY TRANSACTIONS WITH APInnSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.98%
Turnout: all 17.74% · promoters 0.00% · institutions 88.69% · other public 0.41%
- GRANTING OF EMPLOYEES STOCK OPTION FORn FINANCIAL YEAR 2021-22nSpecial96.21% for3.79% against
Against: promoters 0.00% · institutions 20.08% · other public 1.23%
Turnout: all 87.77% · promoters 100.00% · institutions 82.94% · other public 0.41%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 30 Jun 2026, 12 fund houses
To receive, consider and adopt: a) the audited standalone financial statements of the Company for the financial year ended March 31, 2026, together with the Board’s Report and the Auditors’ Report thereon; and b) the audited consolidated financial statements of the Company for the financial year ended March 31, 2026, together with the Auditors’ Report thereonMoreLess
12 for0 againstTo declare a final dividend of Rs. 7.00/- per equity share and to confirm the payment of interim dividend of Rs. 7.00/- per equity share (pre-bonus issue) [equivalent to Rs. 2.33 per equity share post bonus adjustment] on equity share having face value of Rs. 10/- each for the financial year ended March 31, 2026MoreLess
12 for0 against- To re-appoint Mr. Alok Kumar Jagnani (DIN: 00644360), who retires by rotation and being eligible, offers himself for re-appointment12 for0 against
To appoint M/s. Price Waterhouse Chartered Accountants LLP (ICAI Firm Registration No. 012754N/N500016), Chartered Accountants, as Statutory Auditors of the Company for a first term of five consecutive years and to fix their remunerationMoreLess
12 for0 against- Ratification of the remuneration of M/s. Jitender Navneet & Co., Cost Accountants, the Cost Auditors of the Company12 for0 against
- Approval for entering into Material Related Party Transactions with Docon Technologies Private Limited.12 for0 against
- Approval for the appointment of Mr. Gaurav Verma (DIN: 11692586) as Director (Non-Executive and Non-Independent) of the Company with effect from May 08, 202612 for0 against
- Approval for the appointment of Mr. Uday Patel Kadam (DIN: 09277168) as Director (Non- Executive and Non-Independent) of the Company with effect from May 08, 202612 for0 against
Approval for the re-appointment of Mr. Rahul Franklin Guha (DIN: 09588432) as Chairman, Managing Director (MD) and Chief Executive Officer (CEO) of the Company with effect from May 04, 2027 and approve the remuneration payable to him.MoreLess
Against Mirae Asset Mutual Fund
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
11 for1 against- Approval for the amendment in the Memorandum of Association (MOA) of the Company12 for0 against
Mutual fund votes, meeting of 16 Nov 2025, 14 fund houses
- Increase in the Authorised Share Capital and consequent alteration to the Capital Clause of the Memorandum of Association of the Company.14 for0 against
- Alteration of the Articles of Association14 for0 against
- Issuance of Bonus Shares14 for0 against
6 earlier meetings
Mutual fund votes, meeting of 26 Sep 2025, 8 fund houses
- Appointment of Mr. Alok Kumar Jagnani (DIN: 00644360) as a Director (Non- Executive & Non- Independent) of the Company.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundNo concern on the merits of the proposed appointee. The appointment is non-compliant with Companies Act, 2013 and SEBI LODR 2015: Delayed shareholders’ approval. Additional Directorship ceased on 31st July, 2025 (date of AGM) as the appointment was valid only till the date of the said AGM.
6 for2 against
Mutual fund votes, meeting of 31 Jul 2025, 9 fund houses
To receive, consider and adopt: (a) the Audited Standalone Financial Statements of the Company for the Financial Year ended on March 31, 2025; together with the Board’s Report and the Auditors’ Report thereon; and (b) the Audited Consolidated Financial Statements of the Company for the Financial Year ended on March 31, 2025, together with the Auditors’ Report thereon.MoreLess
9 for0 against- To declare a Final Dividend of ₹ 21 per equity share of the face value of ₹ 10 each for the Financial Year ended on March 31, 2025.9 for0 against
- To re-appoint Dr. Dhaval Shah (DIN: 07485688), who retires by rotation, and being eligible, offers himself for re-appointment9 for0 against
- Ratification of Remuneration to the Cost Auditors for the financial year 2025-269 for0 against
- Approval for entering into material related party transactions with Docon Technologies Private Limited9 for0 against
- Appointment of Secretarial Auditors of the Company9 for0 against
Mutual fund votes, meeting of 9 Jan 2025, 6 fund houses
- Extension of the Thyrocare Employees Stock Option Scheme to eligible employee(s) of the Holding and/or Subsidiary Companies of the Company.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, quant Mutual Fund, WhiteOak Capital Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Inadequate disclosures regarding the Exercise Price/Pricing Formula &Exercise period. Governance & Transparency Concern: Extension of scheme to employees of group company without compelling reasons / cost not reimbursed to the Company; Discrepancy in terms of Scheme as disclosed in AGM Notice for FY 2023..
- Nippon India Mutual FundInadequate Disclosure
- quant Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Inadequate disclosures regarding the Exercise Price/Pricing Formula &Exercise period. Governance & Transparency Concern: Extension of scheme to employees of group company without compelling reasons / cost not reimbursed to the Company; Discrepancy in terms of Scheme as disclosed in AGM Notice for FY 2023. In regards to the non-disclosures of Exercise Price or Pricing Formula and Exercise period, inadequate disclosures regarding these amounts to non-compliance of the Part C of Schedule I of SEBI (SBEB) Regulations. The requirement of disclosures intends that the shareholders could estimate the economic benefit proposed to be transferred to its employees during the course of time. Non-disclosure or authorizing Board to decide such particulars defeats the purpose of SEBI requiring Companies to disclose such information. With regard to the benefits proposed to be extended to Group Companies other than Subsidiary Companies without compelling justification or cost reimbursement provision, the clarification given by the Company does not address the concerns.
- WhiteOak Capital Mutual FundThrough this resolution, the company seeks to extend the ESOP Scheme to the employees of holding company (including ultimate holding company) and/or subsidiary companies. API Holdings Limited (the ultimate holding company of Thyrocare Technologies Limited), has its own ESOP Scheme. The Company wishes to further extend ESOPs of Thyrocare Technologies to employees of API Holdings Limited (ultimate holding company). Hence, we do not support the resolution.
1 for5 against
Mutual fund votes, meeting of 23 Aug 2024, 5 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
1 - (a)tTo adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2024, together with the Board’s Report and the Auditors’ Report thereon; andnn(b)t To adopt the audited consolidated financial statements of the Company for the financial year ended March 31, 2024, together with the Auditors’ Report thereon.MoreLess
5 for0 against- To declare dividend of Rs.18/- per equity share of face value of Rs.10/- each for the financial year 2023-24.5 for0 against
- To appoint a director in the place of Mr. Hardik Dedhia (DIN: 06660799), who retires by rotation, and being eligible, offers himself re-appointment.5 for0 against
- To approve appointment of Mr. Nishant Amilal Shah (DIN: 09025935) as an Independent Director.5 for0 against
- To approve appointment of Mr. Anandh Sundar (DIN: 10409065) as an Independent Director.5 for0 against
- To ratify / approve the remuneration fixed for the cost auditor for the financial year 2024-25.1 for0 against
- To approve entering into material related party transactions with Docon Technologies Private Limited.5 for0 against
- To authorise the Board to make investments, give loans, guarantees and security in excess of limits specified under Section 186 of the Companies Act, 2013.
Against DSP Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund
- DSP Mutual FundAs per the company’s balance sheet as on 31 March 2024, the current maximum limit available to provide loans/guarantees/make investments is Rs 4.1 bn. As on 31 March 2024, the company has not given any loans, guarantees or made any investments under section 186. The company has disclosed that it has long-term business plans which may require making loans/investments, acquisitions or issuing guarantees/securities. However, the company has not disclosed any granular details of its business plan to justify the transaction limit sought. The approval is enabling, and it could allow the company to give loans / guarantees / provide securities to any company in which directors are interested, including promoter companies. The company must disclose granular details including names of these companies, the nature and size of their operations and terms of support, to enable shareholders to make an informed decision.Further, the company proposes to increase the limit to Rs. 5.0 bn over and above the statutory limit. However, we do not favour rolling limits linked to net worth and recommend that companies seek approval for a fixed intercorporate transaction limit. Given the lack of clarity, we are unable to support the enabling resolution.
- HDFC Mutual FundGiven these are rolling limits linked to networth, shareholders will not get a chance to periodic review th e borrowing limits
- ICICI Prudential Mutual FundThe company has not shared granular details about the business plans to justify the transaction limit sought for making loans/investments, acquisitions or issuing guarantees/securities, over and above the specified regulatory limits. Hence, in absence of the details, the AMC has voted against the resolution.
- Motilal Oswal Mutual Fund, Nippon India Mutual FundCompliant with law. Governance Concern: Blanket approval proposed without adequate disclosures.
0 for5 against
2 proposals not matched to one resolution
- Adoption of consolidated financial statements for the year ended 31 March 20241 for0 against
Ratification of remuneration of Rs. 1,00,000/- plus applicable taxes and reimbursement of out- of- pocket expenses payable to Mr. S. Thangavelu, Cost and Management Accountant having Membership No. 11315 the Cost Auditor appointed by the Board of Directors, to conduct the audit of cost records of the Company for the financial year ending March 31, 2025.MoreLess
4 for0 against
Mutual fund votes, meeting of 10 Aug 2023, 3 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended March 31, 2023, together with the Board’s Report and the Auditors’ Report thereon; and the audited consolidated financial statements of the Company for the financial year ended March 31, 2023, together with the Auditors’ Report thereonMoreLess
3 for0 against- To confirm the payment of Interim Dividend of Rs.18/- per equity share already paid for the Financial Year 2022-23 and treat it as the Final Dividend for the financial year 2022-233 for0 against
- To appoint a Director in the place of Mr. Dharmil Sheth (DIN: 06999772), who retires by rotation, and being eligible, offers himself for re-appointment3 for0 against
- Appointment of Mr. Rahul Guha (DIN: 09588432), Managing Director and Chief Executive Officer as Chairman of the Company3 for0 against
- Reappointment of Dr. Indumati Gopinathan (DIN: 06779331) as a Non-Executive Independent Director3 for0 against
- Appointment of Dr. Prapti Ishwar Gilada (DIN: 07125024) as a Non-Executive Independent Director3 for0 against
- Appointment of Dr. Harshil Jiten Vora (DIN:10232581) as a Non-Executive Independent Director3 for0 against
- Ratification of remuneration to the cost auditor for the financial year 2023-243 for0 against
- Approval for entering into material related party transactions with Docon Technologies Private Limited3 for0 against
- Amendment in the Employee Stock Option Scheme3 for0 against
Granting of Employees Stock Option for financial year 2023-24 and subsequent years in accordance with the revised scheme until the remaining 218,662 stock options are fully utilised and equivalent no. of shares and issued and allottedMoreLess
3 for0 against
1 proposal not matched to one resolution
- To receive, consider and adopt: the audited consolidated financial statements of the Company for the financial year ended March 31, 2023, together with the Auditors’ Report thereon.1 for0 against
Mutual fund votes, meeting of 3 Aug 2022, 3 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- To receive, consider and adopt the Stand-alone Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Board’s Report and Auditors’ Report thereon.3 for0 against
- To receive, consider and adopt the Consolidated Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Auditors’ Report thereon3 for0 against
- To confirm the payment of Interim Dividend of Rs.15/- per equity share already paid, and approve it as the Final Dividend for the Financial Year 2021-223 for0 against
- TO APPROVE THE APPOINTMENT OF MR. DHARMIL SHETH (DIN: 06999772) AS A DIRECTOR LIABLE TO RETIRE BY ROTATION3 for0 against
- TO APPROVE THE APPOINTMENT OF MR. HARDIK DEDHIA (DIN: 06660799) AS A DIRECTOR LIABLE TO RETIRE BY ROTATION3 for0 against
- TO APPROVE THE APPOINTMENT OF DR. DHAVAL SHAH (DIN: 07485688) AS DIRECTOR LIABLE TO RETIRE BY ROTATION3 for0 against
TO APPROVE THE APPOINTMENT OF MR_RAHUL GUHA (DIN: 09588432) AS, MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER OF THE COMPANY, NOT LIABLE TO RETIRE BY ROTATION AND APPROVE THE REMUNERATION PAYABLE TO HIMMoreLess
3 for0 against- RATIFICATION OF REMUNERATION TO THE COST AUDITOR FOR THE FINANCIAL YEAR 2021-22n3 for0 against
- GRANTING OF EMPLOYEES STOCK OPTION FORn FINANCIAL YEAR 2021-22n3 for0 against
4 proposals not matched to one resolution
Ratification of remuneration of Rs.1,00,000/- (Rupees One Lakh only) fixed by the Board of Directors payable to Mr. S. Thangavelu, Cost and Management Accountant, appointed as the Cost Auditor for conducting audit of the cost records of the Company for the financial year 2022-23 , excluding applicable tax, if any, and reimbursement of travelling and other out-of-pocket expenses.MoreLess
2 for0 againstTo enter into Material Related Party Transaction(s) by way of Contract(s) /Arrangement(s) / Agreement(s) with API Holdings Limited, the ultimate holding company of the Company, which is a ‘Related Party’ under the provisions of Section 2(76) of the Act and Regulation 2(1) (zb) of the SEBI Listing Regulations, for rendering of Diagnostic Services up to a value not exceeding Rs. 100 crores, (in one transaction or series of transactions) up to the next AGM of the Company (for a period not exceeding fifteen months), in the ordinary course of business and at arm’s lengthMoreLess
1 for0 againstTo enter into Material Related Party Transaction(s) by way of Contract(s) /Arrangement(s) / Agreement(s) with API Holdings Limited, the ultimate holding company of the Company, which is a ‘Related Party’ under the provisions of Section 2(76) of the Act and Regulation 2(1) (zb) of the SEBI Listing Regulations, for rendering of Diagnostic Services up to a value not exceeding Rs. 100 crores, (in one transaction or series of transactions) up to the next AGM of the Company (for a period not exceeding fifteen months).MoreLess
2 for0 againstTo ratify the remuneration payable to Mr. S. Thangavelu, Cost and Management Accountant, appointed as the Cost Auditor of the Company, for conducting audit of the cost records of the Company for conducting audit of the cost records of the Company for the financial year 2022-23MoreLess
1 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines and tax disputes
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyDeputy Commissioner of State Tax, Sanpada-502, Raigad Division, MaharashtraSince 5 Aug 2026
A Notice of Discrepancy under Section 65(6) of the MGST/CGST Act, 2017 read with Rule 101(5) of the CGST/MGST Rules 2017 was issued in respect of FY 2022–23 proposing a tax demand of Rs. 1,62,140 interest of Rs. 1,12,688 and a penalty of Rs. 1,00,000, aggregating to Rs. 3,74,828.
The notice alleges (i) non-reversal of ITC, along with applicable interest, on payments not made to suppliers within 180 days (ii) availment of ITC not reflected in Form GSTR-2B and (iii) incorrect reporting of ITC reversals in Table 4(B)(2) instead of Table 4(B)(1) of Form GSTR-3B.MoreLess
- Tax disputeAssessment Unit, Income Tax DepartmentSince 27 Mar 2026The Company has filed an appeal before the appropriate appellate authority and the matter is currently pending
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.